Back to Search Start Over

COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain

Authors :
Candela Calle
Esteve Fernández
Adaia Albasanz-Puig
Carlota Gudiol
Anna Saura-Lazaro
Jordi Trelis
Eva Loureiro
Delphine Casabonne
Maria Ángeles Domínguez
Paula Peremiquel-Trillas
Laia Alemany
Yolanda Benavente-Moreno
Sandra Cabrera
Angela Duran
Lidia Garrote
Immaculada Brao
Maica Galán
Francesc Soler
Joaquim Julià
Dolça Cortasa
Dolors Ramírez-Tarruella
Joan Muniesa
Juan Pedro Rivas
Carles Muñoz-Montplet
Ana Sedano
Àngel Plans
Beatriz Calvo-Cerrada
Ana Clopés
Dolors Carnicer-Pont
Source :
BMJ Open, Vol 12, Iss 4 (2022)
Publication Year :
2022
Publisher :
BMJ Publishing Group, 2022.

Abstract

Objectives Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours.Design Cross-sectional study (21 May 2020–26 June 2020).Setting A comprehensive cancer centre (Institut Català d’Oncologia) in Catalonia, Spain.Participants All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection.Primary outcome measure Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated.Results A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25–p75: 34.8–51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52).Conclusions At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d’Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental.

Subjects

Subjects :
Medicine

Details

Language :
English
ISSN :
20210566 and 20446055
Volume :
12
Issue :
4
Database :
Directory of Open Access Journals
Journal :
BMJ Open
Publication Type :
Academic Journal
Accession number :
edsdoj.67fe62624bc4414986697e186958728d
Document Type :
article
Full Text :
https://doi.org/10.1136/bmjopen-2021-056637